Development / evidence stage

Approved

Abstract editorial illustration of stylised immune cells in cyan surrounding violet tumor cells, with molecular shapes suggesting targeted drugs; an original illustration, not a microscope image.

Cancer Frontiers

Approved

The New Cancer Toolkit: Immunotherapy, Targeted Drugs, Cell Therapy, and Precision Oncology

Targeted drugs, checkpoint inhibitors, CAR-T cells and biomarker testing have joined surgery, radiation and chemotherapy. Each works differently, helps some patients dramatically and others not at all.

Explainer5 min readSep 24, 2026

Abstract editorial illustration of three parallel strands—one receiving a new segment, one being precisely snipped, one being dimmed—representing gene therapy, gene editing and RNA medicines.

Genome + Cells

Approved

Gene Editing, Gene Therapy, and RNA Medicines: Three Different Ways to Change an Outcome

In December 2023 the FDA approved Casgevy, the first CRISPR-based therapy, for sickle cell disease. Here is how gene editing, gene therapy and RNA medicines differ, and what that approval does and doesn't prove.

Feature6 min readSep 19, 2026